The global healthcare contract development and manufacturing organization market size was valued at USD 232.7 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 9.5% from 2023 to 2030. An increase in the uptake of outsourcing services by pharmaceutical companies and growth in R&D investments are expected to drive the market. Medical devices & pharmaceutical companies are outsourcing low-end services to reduce the overall cost of production.
Read More »June 29, 2023
The global biopharmaceutical CMO and CRO market size was valued at USD 36.21 billion in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 5.6% from 2024 to 2030. There was unprecedented growth in 2020 due to the COVID-19 pandemic. The rising investments in the biopharmaceutical industry by the prominent participants to enhance their productivity and efficiency have driven the bio manufacturers to increase their focus on outsourcing activities.
Read More »January 6, 2022
The global large molecule drug substance CDMO market size was valued at USD 11.5 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 9.3% from 2023 to 2030. Increasing large molecule drug approvals, primarily with the FDA, rising incidence of infectious diseases, high demand for novel therapeutics, and higher capital investments by pharma and biotech firms in advanced technologies for establishing partnerships with CDMOs are the key factors driving the market.
Read More »November 23, 2022
The U.S. biopharmaceutical CMO & CRO market size was valued at USD 10.1 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.1% from 2023 to 2030. Increasing adoption and investment in advanced research and manufacturing technologies by Contract Manufacturing Organizations (CMOs) & Contract Research Organizations (CROs) based in the U.S. is propelling the growth of the biopharmaceutical CMO & CRO market in the country.
Read More »February 28, 2023
The global investigational new drug CDMO market size was valued at USD 4.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.9% from 2021 to 2028. The market growth can be attributed to factors such as the increasing outsourcing services by pharmaceutical companies, rising R&D investments, and stringent regulations for conducting clinical studies. The FDA's role in the development of a novel drug begins when the drug's sponsor decides to test the new molecule's diagnostic or therapeutic potential in humans after screening it for pharmacological activity and acute toxicity potential in animals.
Read More »September 17, 2021
Our healthcare portfolio has been developing since our inception in 2014, wherein we have tracked numerous sub-domains and their R&D activities. We have actively been tracking the CROs space and have seen the evolution of these players from just a handful to now over 100 companies.
Read More »April 12, 2023
The global topical drugs CDMO market size was estimated at USD 41.54 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 11.4% from 2024 to 2030. Growth in the aesthetic and cosmetic industry has significantly driven demand for topical drugs, thereby simultaneously boosting demand for contract development and manufacturing services.
Read More »November 2, 2023
The North America topical drugs CDMO market size was estimated at USD 13.03 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 10.7% from 2024 to 2030. Rising healthcare outsourcing, improved patient care, R&D investments due to rising prevalence of various skin diseases, and expiration of existing patents are driving the topical drugs CDMO market in North America.
Read More »January 31, 2024
The global smart contracts market size was valued at USD 684.3 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 82.2% from 2023 to 2030. The growth is primarily driven by the increasing adoption of blockchain technology, technological innovation, increased efficiency, cost savings, and the growing demand for Decentralized Finance (DeFi).
Read More »May 24, 2023
The global pharmaceutical contract manufacturing and research services market size was valued at USD 226.6 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.10% from 2023 to 2030. Cost-saving and time-saving benefits associated with the implementation of outsourcing are responsible for driving the market
Read More »April 20, 2022